How much does a box of imported Bosutinib cost and where to buy it?

Bosutinib is an oral tyrosine kinase inhibitor (TKI), mainly used to treat Philadelphia chromosome-positive chronic myelogenous leukemia (Ph+ CML), especially for patients who have failed or are intolerant to other TKI treatments. As of now, bosutinib has not yet received marketing approval from the National Food and Drug Administration (NMPA) in mainland China. Therefore, domestic hospitals and pharmacies are temporarily unable to provide the drug. If patients need medication, they can only purchase it through formal overseas channels.

The original version of bosutinib was developed and produced by Pfizer, and has been officially launched in many countries such as Europe, the United States, and Japan for the treatment of CML. The common specification of the European version of the original drug is 500mg*28 tablets, which is about a one-month standard treatment course. According to the current market conditions, a box of original medicine of this specification is priced at more than 30,000 yuan, which is relatively expensive. It is suitable for patients who have high requirements on brand and quality and whose economic conditions permit, to ensure the efficacy and safety of the medication.

Considering the high price of the original drug, the well-known Indian pharmaceutical company Mylan (Mylan) has launched a generic version of bosutinib. Its ingredients, dosage and efficacy are basically the same as the original drug, and it has been approved by the local drug regulatory department. Widely used in overseas markets. This generic drug is also in the specification of 500mg*28 tablets. The price per box is about more than 1,000 yuan. It has obvious price advantages and is suitable for long-term medication patients to reduce financial pressure. Generic drugs are also an important alternative to bosutinib for many patients.

At present, if domestic patients need to use bosutinib, they can order it through formal cross-border medical platforms, overseas pharmacy purchasing agencies or certified third-party channels. When choosing a purchasing channel, priority should be given to legal, safe, and traceable sources of drugs to avoid purchasing fake or inferior drugs. It is recommended to evaluate the condition and drug adaptability under the guidance of a doctor before taking medication, and regularly monitor blood routine, liver and kidney function and other indicators to ensure treatment effects and physical safety.

Reference materials:https://www.drugs.com/

xa0